Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 635 |
|
|||||
| News | - | ||||||
| Day High | 2.20 | Low High |
|||||
| Day Low | 2.14 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| CytoMed Therapeutics Ltd | GDTC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.03 | 1.42% | 2.14 | 18:04:42 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.20 | 2.14 | 2.20 | 2.14 | 2.11 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 16 | 635 | US$ 2.18 | US$ 1,384 | - | 1.92 - 9.25 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:05:18 | 58 | US$ 2.15 | USD |
CytoMed Therapeutics Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 24.67M | 11.53M | - | 484k | -3.13M | -0.27 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
CytoMed Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GDTC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.19 | 2.24 | 2.06 | 2.11 | 14,673 | -0.05 | -2.28% |
| 1 Month | 2.03 | 2.25 | 2.00 | 2.11 | 6,416 | 0.11 | 5.42% |
| 3 Months | 2.88 | 2.88 | 1.92 | 2.22 | 15,549 | -0.74 | -25.69% |
| 6 Months | 3.75 | 5.50 | 1.92 | 3.80 | 31,392 | -1.61 | -42.93% |
| 1 Year | 3.43 | 9.25 | 1.92 | 4.88 | 142,614 | -1.29 | -37.61% |
| 3 Years | 4.00 | 9.25 | 1.92 | 4.79 | 147,595 | -1.86 | -46.50% |
| 5 Years | 4.00 | 9.25 | 1.92 | 4.79 | 147,595 | -1.86 | -46.50% |
CytoMed Therapeutics Description
| CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. |
